BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Australia’s Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-upTop-line phase 2 trial data shows disease modifying potential and pain reduction

  Australia’s Paradigm Biopharmaceuticals Ltd says analysis of six-month trial data shows injectable pentosan polysulfate sodium may slow the progression of osteoarthritis of the knee.

  April 11, 2023

   · 

  4 min read
• Drug Development

  Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia

  Airway Therapeutics, Inc. announced it successfully finished the dose escalation portion of its Phase 1b trial of zelpultide alfa for preventive use in very preterm infants at risk for bronchopulmonary dysplasia.

  April 11, 2023

   · 

  2 min read
• Q3 FY23 Business Update Webinar Notification

  Immuron Limited is pleased to advise it will provide a business update for the quarter ended 31 March 2023.

  April 11, 2023

   · 

  2 min read
• BioMidwest

  Bexion Pharmaceuticals, Inc. to Present at the 22nd Annual Needham Virtual Healthcare Conference

  Bexion Pharmaceuticals, Inc. announced that Bexion Pharmaceuticals will be presenting at the Needham Healthcare Conference.

  April 11, 2023

   · 

  1 min read
• Drug Development

  HI-Bio Announces Positive Phase 2 Data on Felzartamab for the Treatment of Primary Membranous Nephropathy

  Human Immunology Biosciences announced positive data from two Phase 2 studies of felzartamab, M-PLACE and NewPLACE.

  April 11, 2023

   · 

  8 min read
• BioMidwest

  Rockwell Medical to Exhibit at the National Kidney Foundation SCM23

  Rockwell Medical, Inc. announced that the Company is exhibiting its hemodialysis concentrates portfolio in Booth #503 at the National Kidney Foundation Spring Clinical Meetings, which will be held April 11-15, 2023 at the Austin Convention Center in Austin, Texas.

  April 11, 2023

   · 

  3 min read
• BioMidwest

  SentiAR Announces Close of $8.5 million Series B Financing

  SentiAR, Inc. a St. Louis, Missouri based pioneer in using Augmented Reality visualization technology for medical procedures, has closed an $8.5 million Series B financing.

  April 11, 2023

   · 

  3 min read
• Beactica Therapeutics to present update on LSD1 programme at the AACR Annual Meeting 2023

  Beactica Therapeutics AB, the Swedish precision oncology company, announced that its LSD1 programme has been selected for a poster presentation at the American Association for Cancer Research’s Annual Meeting 2023.

  April 11, 2023

   · 

  2 min read
• Biotech Bay

  Annexon Biosciences to Participate in the 22nd Annual Needham Virtual Healthcare Conference

  Annexon, Inc. announced that Douglas Love, president and chief executive officer, will participate in a fireside chat during the 22nd Annual Needham Virtual Healthcare Conference on Tuesday, April 18, 2023 at 1:30 p.m. ET.

  April 11, 2023

   · 

  1 min read
• Business

  Cerevel Therapeutics to Report First Quarter 2023 Financial Results and Business Updates on Wednesday, May 3, 2023

  Cerevel Therapeutics announced it will report first quarter 2023 financial results and business updates on Wednesday, May 3, 2023, before the U.S. financial markets open.

  April 11, 2023

   · 

  4 min read